- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lymphocytic Leukemia in New Zealand
Total 1535 results
-
Maxim PharmaceuticalsCompletedLeukemiaUnited States, France, Israel, Australia, Canada, Sweden, Finland, Germany, New Zealand, Denmark, Estonia, United Kingdom
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia... and other conditionsUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedAcute Myelogenous LeukemiaUnited States
-
Dana-Farber Cancer InstituteBoston Children's HospitalTerminatedAcute Lymphoblastic LeukemiaUnited States, Puerto Rico, Canada
-
Memorial Sloan Kettering Cancer CenterRecruitingRefractory Acute Lymphoblastic Leukemia | Philadelphia-Negative ALL | Philadelphia-Positive ALL | Refractory Acute Lymphoblastic Leukemia (ALL) | Relapsed ALL, Adult | Refractory Acute Lymphoid Leukemia in RelapseUnited States
-
Marker Therapeutics, Inc.Active, not recruitingAcute Myeloid Leukemia | Stem Cell TransplantationUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingAcute Lymphoblastic Leukemia, PediatricUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)Completed
-
Boehringer IngelheimCompletedLeukemia, Myeloid, AcuteUnited States
-
CSL LimitedParexelCompletedLeukemia, Myeloid, AcuteUnited States, Australia
-
Ariad PharmaceuticalsUnited BioSource, LLCTerminatedMyeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALLUnited States
-
Ioannis MantzarisAbbVieRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
New York Medical CollegeCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
New York Medical CollegeCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Arcellx, Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMyelodysplastic Syndromes (MDS) | Acute Myelogenous Leukemia (AML)United States
-
Cornerstone PharmaceuticalsWithdrawnAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
Kirby InstituteCelgeneCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia
-
Aptose Biosciences Inc.Ohio State UniversityCompletedAcute Myeloid LeukemiaUnited States
-
University of UtahCelgeneCompletedChronic Myelomonocytic LeukemiaUnited States
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterTerminatedRecurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1United States
-
Christian Medical College, Vellore, IndiaMinistry of Science and Technology, IndiaUnknownAcute Promyelocytic LeukemiaIndia
-
Onconova Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Polish Adult Leukemia GroupRecruiting
-
NovartisNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic... and other conditionsUnited States
-
NovartisCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte Corporation; H. Jean Khoury Cure CML ConsortiumRecruitingChronic Myeloid Leukemia, Chronic Phase | Chronic Phase Chronic Myeloid LeukemiaUnited States
-
Ascenta TherapeuticsThe Leukemia and Lymphoma SocietyTerminated
-
National Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Adult Acute Myeloid Leukemia With Maturation | Adult Acute Myeloid Leukemia With Minimal... and other conditionsUnited States
-
The Hospital for Sick ChildrenChildren's Hospital Los Angeles; Rutgers Cancer Institute of New Jersey; Inova...Recruiting
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States, Canada
-
Merck Sharp & Dohme LLCTerminatedRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Chronic Myelomonocytic LeukemiaUnited States, Israel, Spain
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedLeukemia | Acute Lymphoblastic LeukemiaUnited States
-
Roswell Park Cancer InstituteCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Alkylating Agent-Related Acute Myeloid Leukemia | Refractory Anemia With Excess Blasts in TransformationUnited States
-
University of SydneyUnknown
-
Memorial Sloan Kettering Cancer CenterNovartis Pharmaceuticals; Incyte CorporationActive, not recruiting
-
Kura Oncology, Inc.RecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Myeloid Sarcoma | Acute Myeloid Leukemia Recurrent | Mixed Phenotype Acute Leukemia | Mixed Lineage Acute Leukemia | Refractory AML | NPM1 Mutation | Mixed Lineage Leukemia Gene Mutation | AML With Mutated NPM1 | KMT2ArUnited States
-
Bristol-Myers SquibbPfizerCompletedLymphoma | Acute Lymphoblastic LeukemiaUnited States, Canada, Mexico, Belgium, Russian Federation, Hungary, Korea, Republic of, Australia, Puerto Rico, Czechia, New Zealand, Poland
-
PfizerCompleted
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia | Advanced Solid TumorsUnited States
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaCanada, United States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Recurrent Adult Burkitt Lymphoma | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingAcute Lymphoblastic LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruitingAcute Lymphoblastic LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States
-
ALX Oncology Inc.Active, not recruitingA Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)Acute Myeloid Leukemia | AML, AdultUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Childhood T Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, New Zealand
-
Roswell Park Cancer InstituteCelgeneWithdrawnRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | IDH2 Gene Mutation | Blasts Under 5 Percent of Peripheral Blood White Cells | Bone Marrow Blasts Decreased by 50 Percent or More Compared to Pretreatment LevelUnited States